To investigate FOXC1 chromatin binding, and the effect of FOXC1 CRISPR knockout in triple negative breast cancer cell lines MDA-MB-231, MDA-MB-468, Hs578t, and Bt-549. Overall design: We performed RNA-seq on WT and FOXC1 KO lines, and ChIP-seq for FOXC1 on WT cell lines.